Aytu BioPharma, Inc.AYTUNASDAQ

Revenue (LTM)

$66M

+1.8% YoY

Net Income (LTM)

$-14M

+14.4% YoY

Free Cash Flow

$-5M

Revenue CAGR (5Y)

+0.3%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Revenue	66	97↑47.3%	107↑11.1%	65↓39.3%	66↑1.8%
Gross Profit	29	50↑72.2%	67↑32.5%	49↓26.4%	46↓6.6%
Operating Income	-59	-110↓86.7%	-17↑84.5%	-2↑90.7%	-8↓392.0%
Net Income	-58	-109↓86.6%	-17↑84.3%	-16↑7.1%	-14↑14.4%
EBITDA	-29	-28↑3.7%	-3↑88.3%	1↑143.0%	-5↓431.8%
EPS Diluted	-69.60	-74.01↓6.3%	-5.11↑93.1%	-2.86↑44.0%	-2.16↑24.5%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Cash & Equivalents	50	19↓61.0%	23↑18.7%	20↓13.0%	31↑54.7%
Total Current Assets	105	60↓43.1%	73↑21.5%	62↓15.0%	79↑27.9%
Total Assets	266	138↓48.2%	138↑0.2%	119↓13.8%	124↑4.5%
Total Current Liabilities	109	64↓41.1%	69↑7.1%	62↓9.8%	63↑1.3%
Total Liabilities	128	93↓27.2%	98↑5.5%	91↓7.5%	105↑15.4%
Total Equity	138	44↓67.8%	39↓11.2%	28↓29.6%	19↓31.6%
Total Debt	31	18↓41.3%	30↑67.3%	16↓46.0%	23↑39.7%
Net Debt	-19	-1↑93.7%	7↑734.9%	-4↓148.2%	-8↓123.4%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Operating Cash Flow	-26	-29↓11.0%	-5↑82.2%	-1↑72.9%	-2↓39.6%
Capital Expenditure	0	0	0	-0	-3↓881.2%
Free Cash Flow	-26	-29↓11.0%	-5↑82.2%	-2↑66.5%	-5↓200.8%
Stock-Based Comp	4	5↑46.8%	6↑15.2%	2↓60.8%	1↓75.7%
Net Change in Cash	2	-31↓2047.8%	4↑111.9%	-3↓182.2%	11↑467.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance